N-(6,7-Dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-d-aspartate receptor antagonists for the treatment of pain

Christopher Deur; Arun K. Agrawal; Heidi Baum; John Booth; Susan Bove; Joan Brieland; Amy Bunker; Cleo Connolly; Joseph Cornicelli; Jo Ann Dumin; Barry Finzel; Xinmin Gan; Sheila Guppy; Gregg Kamilar; Kenneth Kilgore; Pil Lee; Cho Ming Loi; Zhen Lou; Mark Morris; Laurence Philippe; Sally Przybranowski; Frank Riley; Brian Samas; Brian Sanchez; Haile Tecle; Ziqiang Wang; Kathryn Welch; Michael Wilson; Karen Yates

doi:10.1016/j.bmcl.2007.05.083

N-(6,7-Dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-d-aspartate receptor antagonists for the treatment of pain

Christopher Deur, Arun K. Agrawal, Heidi Baum, John Booth, Susan Bove, Joan Brieland, Amy Bunker, Cleo Connolly, Joseph Cornicelli, Jo Ann Dumin, Barry Finzel, Xinmin Gan, Sheila Guppy, Gregg Kamilar, Kenneth Kilgore, Pil Lee, Cho Ming Loi, Zhen Lou, Mark Morris, Laurence PhilippeSally Przybranowski, Frank Riley, Brian Samas, Brian Sanchez, Haile Tecle, Ziqiang Wang, Kathryn Welch, Michael Wilson, Karen Yates

Medicinal Chemistry

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

It has been hypothesized that peripherally restricted NMDA receptor antagonists may be effective analgesics for osteoarthritis pain. A class of novel quinoxalinedione atropisomers, first discovered for an NMDA receptor antagonist program for the treatment of stroke, was evaluated and further optimized with the goal of finding peripherally restricted NMDA receptor antagonists.

Original language	English (US)
Pages (from-to)	4599-4603
Number of pages	5
Journal	Bioorganic and Medicinal Chemistry Letters
Volume	17
Issue number	16
DOIs	https://doi.org/10.1016/j.bmcl.2007.05.083
State	Published - Aug 15 2007

Keywords

NMDA antagonist
Osteoarthritis
Pain

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/j.bmcl.2007.05.083

OpenUrl availability

Full text

Cite this

Deur, C., Agrawal, A. K., Baum, H., Booth, J., Bove, S., Brieland, J., Bunker, A., Connolly, C., Cornicelli, J., Dumin, J. A., Finzel, B., Gan, X., Guppy, S., Kamilar, G., Kilgore, K., Lee, P., Loi, C. M., Lou, Z., Morris, M., ... Yates, K. (2007). N-(6,7-Dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-d-aspartate receptor antagonists for the treatment of pain. Bioorganic and Medicinal Chemistry Letters, 17(16), 4599-4603. https://doi.org/10.1016/j.bmcl.2007.05.083

N-(6,7-Dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-d-aspartate receptor antagonists for the treatment of pain. / Deur, Christopher; Agrawal, Arun K.; Baum, Heidi et al.
In: Bioorganic and Medicinal Chemistry Letters, Vol. 17, No. 16, 15.08.2007, p. 4599-4603.

Research output: Contribution to journal › Article › peer-review

Deur, C, Agrawal, AK, Baum, H, Booth, J, Bove, S, Brieland, J, Bunker, A, Connolly, C, Cornicelli, J, Dumin, JA, Finzel, B, Gan, X, Guppy, S, Kamilar, G, Kilgore, K, Lee, P, Loi, CM, Lou, Z, Morris, M, Philippe, L, Przybranowski, S, Riley, F, Samas, B, Sanchez, B, Tecle, H, Wang, Z, Welch, K, Wilson, M & Yates, K 2007, 'N-(6,7-Dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-d-aspartate receptor antagonists for the treatment of pain', Bioorganic and Medicinal Chemistry Letters, vol. 17, no. 16, pp. 4599-4603. https://doi.org/10.1016/j.bmcl.2007.05.083

@article{7b38b0a588eb41fe95ff74ea4deef31e,

title = "N-(6,7-Dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-d-aspartate receptor antagonists for the treatment of pain",

abstract = "It has been hypothesized that peripherally restricted NMDA receptor antagonists may be effective analgesics for osteoarthritis pain. A class of novel quinoxalinedione atropisomers, first discovered for an NMDA receptor antagonist program for the treatment of stroke, was evaluated and further optimized with the goal of finding peripherally restricted NMDA receptor antagonists.",

keywords = "NMDA antagonist, Osteoarthritis, Pain",

author = "Christopher Deur and Agrawal, {Arun K.} and Heidi Baum and John Booth and Susan Bove and Joan Brieland and Amy Bunker and Cleo Connolly and Joseph Cornicelli and Dumin, {Jo Ann} and Barry Finzel and Xinmin Gan and Sheila Guppy and Gregg Kamilar and Kenneth Kilgore and Pil Lee and Loi, {Cho Ming} and Zhen Lou and Mark Morris and Laurence Philippe and Sally Przybranowski and Frank Riley and Brian Samas and Brian Sanchez and Haile Tecle and Ziqiang Wang and Kathryn Welch and Michael Wilson and Karen Yates",

year = "2007",

month = aug,

day = "15",

doi = "10.1016/j.bmcl.2007.05.083",

language = "English (US)",

volume = "17",

pages = "4599--4603",

journal = "Bioorganic and Medicinal Chemistry Letters",

issn = "0960-894X",

publisher = "Elsevier Limited",

number = "16",

}

TY - JOUR

T1 - N-(6,7-Dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-d-aspartate receptor antagonists for the treatment of pain

AU - Deur, Christopher

AU - Agrawal, Arun K.

AU - Baum, Heidi

AU - Booth, John

AU - Bove, Susan

AU - Brieland, Joan

AU - Bunker, Amy

AU - Connolly, Cleo

AU - Cornicelli, Joseph

AU - Dumin, Jo Ann

AU - Finzel, Barry

AU - Gan, Xinmin

AU - Guppy, Sheila

AU - Kamilar, Gregg

AU - Kilgore, Kenneth

AU - Lee, Pil

AU - Loi, Cho Ming

AU - Lou, Zhen

AU - Morris, Mark

AU - Philippe, Laurence

AU - Przybranowski, Sally

AU - Riley, Frank

AU - Samas, Brian

AU - Sanchez, Brian

AU - Tecle, Haile

AU - Wang, Ziqiang

AU - Welch, Kathryn

AU - Wilson, Michael

AU - Yates, Karen

PY - 2007/8/15

Y1 - 2007/8/15

N2 - It has been hypothesized that peripherally restricted NMDA receptor antagonists may be effective analgesics for osteoarthritis pain. A class of novel quinoxalinedione atropisomers, first discovered for an NMDA receptor antagonist program for the treatment of stroke, was evaluated and further optimized with the goal of finding peripherally restricted NMDA receptor antagonists.

AB - It has been hypothesized that peripherally restricted NMDA receptor antagonists may be effective analgesics for osteoarthritis pain. A class of novel quinoxalinedione atropisomers, first discovered for an NMDA receptor antagonist program for the treatment of stroke, was evaluated and further optimized with the goal of finding peripherally restricted NMDA receptor antagonists.

KW - NMDA antagonist

KW - Osteoarthritis

KW - Pain

UR - http://www.scopus.com/inward/record.url?scp=34447340228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447340228&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2007.05.083

DO - 10.1016/j.bmcl.2007.05.083

M3 - Article

C2 - 17562362

AN - SCOPUS:34447340228

SN - 0960-894X

VL - 17

SP - 4599

EP - 4603

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

IS - 16

ER -

N-(6,7-Dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-d-aspartate receptor antagonists for the treatment of pain

Abstract

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this